about
Evolutionary dynamics of cancer in response to targeted combination therapyCancer genome landscapesDigital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patientsAmplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancerIntegrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastomaAn integrated genomic analysis of human glioblastoma multiformeGlucose deprivation contributes to the development of KRAS pathway mutations in tumor cellsA panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53Liquid biopsies: genotyping circulating tumor DNADevelopment of personalized tumor biomarkers using massively parallel sequencingDetection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencingEvaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancersCirculating mutant DNA to assess tumor dynamicsFrequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinomaDAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part oneDetection of circulating tumor DNA in early- and late-stage human malignanciesThe colorectal microRNAomeNon-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease.Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancer.Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.A combination of molecular markers and clinical features improve the classification of pancreatic cysts.The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT.Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CTReversible posterior leukoencephalopathy in an HIV-infected patient with thrombotic thrombocytopenic purpura.Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancerExomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomasA single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis.Sensitive digital quantification of DNA methylation in clinical samples.Antigen selection of anti-DSG1 autoantibodies during and before the onset of endemic pemphigus foliaceus.Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?An insight into the sialotranscriptome of Simulium nigrimanum, a black fly associated with fogo selvagem in South America.Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancerNeuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survivalEradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells.Detection and quantification of mutations in the plasma of patients with colorectal tumors.Subcutaneous Metastatic Adenocarcinoma: An Unusual Presentation of Colon Cancer - Case Report and Literature Review
P50
Q21128788-58EC26C0-A8FA-4829-92F7-6FC100BC5BDCQ22242276-3BDB2352-114D-4680-BCC9-4D92BF1E72B7Q24561669-94439EFE-6682-47A3-B8A7-55B585C752E1Q24563539-6CB220DA-E922-4DCE-98D2-FE3A4A3DD5F4Q24630017-0D290DDD-0D9F-49F6-8271-2B828D6E1DD2Q24648860-77AD47FF-45E9-48D9-B6D7-CC35C04E7711Q24648994-70901CD7-926D-45B7-9C41-CD329149A38AQ24657532-49A11243-17EE-40F7-93BF-133BA9BB46D6Q27010159-5BB72458-6325-4537-B1C1-ACCC03E11A8BQ28278819-A1A2C442-8F7B-48CD-8268-0474CFD47D14Q28280303-AF396733-D8D8-4E64-886F-C1C0F04CB951Q28282973-C2CDC371-D9D1-4665-87ED-E663C9B9FAABQ28289337-F3A94310-0A8F-40D8-89FE-07A960EC018EQ28292742-1626B85C-BA70-466B-BAE0-949F132E6D2CQ28303693-6284438B-47E0-4DAA-B54C-64C8CBB6E949Q28553703-1289605E-3A7A-41AF-AAAF-2B12226C901EQ29615778-8523560D-8DC2-4B9C-8B25-E7C3E2A104A4Q29616082-A2D17A53-803F-4D4E-9348-FD440C3FF6D0Q30249078-6EFC3984-B229-4055-A4C4-E3487170AAA8Q30301247-3D71BB95-73DA-45CA-9680-9FC48FF6A595Q30528894-7C8C9F5F-F989-440A-A2C0-F4B28B270481Q30724746-80ABB98C-7C1B-4892-9313-D6AA6CDF8D64Q33264073-EF6625AD-F884-4D60-8AF6-F12B6D58FD77Q33302104-48A182B0-1B3D-4CA4-9BD3-7F1BF7B3396BQ33344647-11329084-62FF-4B6D-95E5-7047CF6BE6BFQ33401352-8E18E330-8A11-43F6-8CFB-40C99C2772D4Q33554186-FE592761-C714-49AE-AA76-8040B821C2D9Q33720743-A0F71B8A-0201-45C7-B88A-7BEDABDA1567Q33726526-76FC445B-30F7-4142-A77A-875DEBED8309Q33761814-0164BBF6-D10D-4EA3-80EE-0852EFF1132BQ33761903-7266B034-3F3E-4201-BC32-6D927A10BBBFQ33762809-940FDCFD-2D49-412F-9259-5A53C93A2D2FQ33769939-F7C0301F-7B91-46A7-B1AF-8B6FF9DE76B7Q33858586-7FAF2ED9-BD5F-436A-846A-E22387FFB896Q33880640-18257BBF-F1E4-42A0-9EAD-8A3193605B02Q33924966-FE2D4517-32C2-4B6D-9DEB-4282FCE7F472Q33925521-C45B6DDE-BF64-4259-BE45-8A0691094957Q34060558-9B19AA32-C415-4649-92AC-3CA5D4F4CA54Q34132363-A1457864-4C7D-4E28-A626-BBC61D525610Q34353099-6E06AFB6-5266-42A8-B243-0F959E06B882
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luis A Diaz
@ast
Luis A Diaz
@es
Luis A Diaz
@nl
Luis A Diaz
@sl
Luis Alberto Diaz Jr
@en
type
label
Luis A Diaz
@ast
Luis A Diaz
@es
Luis A Diaz
@nl
Luis A Diaz
@sl
Luis Alberto Diaz Jr
@en
altLabel
Luis A Diaz
@en
Luis Diaz
@en
prefLabel
Luis A Diaz
@ast
Luis A Diaz
@es
Luis A Diaz
@nl
Luis A Diaz
@sl
Luis Alberto Diaz Jr
@en
P106
P21
P31
P496
0000-0002-7079-8914